About Tejas Translational Technologies
Tejas Translational Technologies is a company based in Nagercoil (India) founded in 2016. It operates as a B2C and D2C. Tejas Translational Technologies offers products and services including Slot Games, Live Casino, and Sports Betting. Tejas Translational Technologies operates in a competitive market with competitors including TISSIUM, Laminate Medical, Vivasure Medical, Cardival Medical and Saranas, among others.
- Headquarter Nagercoil, India
-
Sectors
Consumer
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Tejas Translational Technologies Private Limited
- Date of Incorporation 24 Mar, 2016
- Jurisdiction Kanyakumari, Tamil Nadu, India
-
Annual Revenue
$3.73 K (USD)0as on Mar 31, 2017
-
Net Profit
-$2.31 K (USD)0as on Mar 31, 2017
-
EBITDA
-$2.06 K (USD)0as on Mar 31, 2017
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Tejas Translational Technologies
Tejas Translational Technologies offers a comprehensive portfolio of products and services, including Slot Games, Live Casino, and Sports Betting.
Platform for playing various slot games with jackpots and rewards
Real-time casino games featuring dealers and interactive play
Service for wagering on sports events through the platform
Funding Insights of Tejas Translational Technologies
Detailed funding history for Tejas Translational Technologies
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Tejas Translational Technologies
Investment portfolio details for Tejas Translational Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Tejas Translational Technologies
Detailed financials for Tejas Translational Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Tejas Translational Technologies Comparisons
Peer comparison for Tejas Translational Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Tejas Translational Technologies
Tejas Translational Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TISSIUM, Laminate Medical, Vivasure Medical, Cardival Medical and Saranas, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Vascular sealants for open surgery are developed by TISSIUM.
|
|
| Locked | Locked | Locked |
AV fistula maturation and patency are supported by VasQ device.
|
|
| Locked | Locked | Locked |
Bioabsorbable implants and delivery systems for arteriotomy closure are developed.
|
|
| Locked | Locked | Locked |
A device for vascular access management is developed.
|
|
| Locked | Locked | Locked |
A device is developed for detecting internal bleeding during catheterization.
|
|
| Locked | Locked | Locked |
Regenerative medicine products are developed for orthopedic and cardiovascular applications.
|
Detailed competitors of Tejas Translational Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Tejas Translational Technologies
Complete news archive for Tejas Translational Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tejas Translational Technologies
Tejas Translational Technologies was founded in 2016.
Tejas Translational Technologies is headquartered in Nagercoil, India. It is registered at Nagercoil, Tamil Nadu, India.
Annual revenue of Tejas Translational Technologies is $3.73K as on Mar 31, 2017.
Matahari168 operates as an online gambling platform in Indonesia, providing access to various slot games, live casino, sports betting, and arcade options from multiple providers. Users can engage in transactions via local banks and e-wallets, participating in jackpots and interactive games. The service focuses on user-friendly gaming experiences while ensuring secure payments and promotions.
Tejas Translational Technologies's top competitors include TISSIUM, Vivasure Medical and Cardival Medical.
Tejas Translational Technologies offers Slot Games, Live Casino, and Sports Betting.